Chiral Active β-Glucan Nanoparticles for Synergistic Delivery of Doxorubicin and Immune Potentiation
Jintao Huang,1,* Chaoxi Wu,2,* Shunqing Tang,3 Pengjun Zhou,2 Jianping Deng,1 Zhen Zhang,1 Yifei Wang,2 Zhiping Wang1 1Guangdong Provincial Engineering Center of Topical Precise Drug Delivery System, School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510632, People’s Republ...
Guardado en:
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2020
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/a39b247770c446ceb1bfa5d5e71750b7 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:a39b247770c446ceb1bfa5d5e71750b7 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:a39b247770c446ceb1bfa5d5e71750b72021-12-02T10:51:19ZChiral Active β-Glucan Nanoparticles for Synergistic Delivery of Doxorubicin and Immune Potentiation1178-2013https://doaj.org/article/a39b247770c446ceb1bfa5d5e71750b72020-07-01T00:00:00Zhttps://www.dovepress.com/chiral-active-beta-glucan-nanoparticles-for-synergistic-delivery-of-do-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Jintao Huang,1,* Chaoxi Wu,2,* Shunqing Tang,3 Pengjun Zhou,2 Jianping Deng,1 Zhen Zhang,1 Yifei Wang,2 Zhiping Wang1 1Guangdong Provincial Engineering Center of Topical Precise Drug Delivery System, School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510632, People’s Republic of China; 2Guangzhou Jinan Biomedicine Research and Development Center, Institute of Biomedicine, College of Life Science and Technology, Jinan University, Guangzhou 510632, People’s Republic of China; 3Biomedical Engineering Institute, Jinan University, Guangzhou 510632, People’s Republic of China*These authors contributed equally to this workCorrespondence: Yifei Wang; Zhiping Wang Email twang-yf@163.com; wzping-jshb@gdpu.edu.cnBackground: β-glucans are chiral polysaccharides with well-defined immunological properties and supramolecular wrapping ability of its chiral feature. However, the exploitation of chiral properties of these nanoparticles in drug delivery systems was seldom conducted.Methods: β-glucan molecules with different chain lengths were extracted from yeast Saccharomyces cerevisiae and thereafter modified. In a conformation transition process, these β-glucan molecules were then self-assembled with anti-cancer drug doxorubicin into nanoparticles to construct drug delivery systems. The chiral interactions between the drug and carriers were revealed by circular dichroism spectra, ultraviolet and visible spectrum, fourier transform infrared spectroscopy, dynamic light scattering and transmission electron microscope. The immune-potentiation properties of modified β-glucan nanoparticles were evaluated by analysis of the mRNA expression in RAW264.7 cell model. Further, the antitumor efficacy of the nanoparticles against the human breast cancer were studied in MCF-7 cell model by cellular uptake and cytotoxicity experiments.Results: β-glucan nanoparticles can activate macrophages to produce immune enhancing cytokines (IL-1β, IL-6, TNF-α, IFN-γ). A special chirality of the carriers in diameter of 50∼ 160 nm can also associate with higher drug loading ability of 13.9% ∼ 38.2% and pH-sensitive release with a change of pH from 7.4 to 5.0. Cellular uptake and cytotoxicity experiments also prove that the chiral-active β-glucan nanoparticles can be used in anti-cancer nanomedicine.Conclusion: This work demonstrates that β-glucans nanoparticles with special chiral feature which leading to strong immunopotentiation ability and high drug loading efficiency can be developed as a novel type of nanomedicine for anti-cancer treatment.Keywords: β-glucan, chiral, nanoparticles, doxorubicin, anti-cancer, drug delivery systems, immune-potentiationHuang JWu CTang SZhou PDeng JZhang ZWang YWang ZDove Medical Pressarticle-glucanchiralnanoparticlesdoxorubicinanti-cancerdrug delivery systemsimmune-potentiationMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 15, Pp 5083-5095 (2020) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
-glucan chiral nanoparticles doxorubicin anti-cancer drug delivery systems immune-potentiation Medicine (General) R5-920 |
| spellingShingle |
-glucan chiral nanoparticles doxorubicin anti-cancer drug delivery systems immune-potentiation Medicine (General) R5-920 Huang J Wu C Tang S Zhou P Deng J Zhang Z Wang Y Wang Z Chiral Active β-Glucan Nanoparticles for Synergistic Delivery of Doxorubicin and Immune Potentiation |
| description |
Jintao Huang,1,* Chaoxi Wu,2,* Shunqing Tang,3 Pengjun Zhou,2 Jianping Deng,1 Zhen Zhang,1 Yifei Wang,2 Zhiping Wang1 1Guangdong Provincial Engineering Center of Topical Precise Drug Delivery System, School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510632, People’s Republic of China; 2Guangzhou Jinan Biomedicine Research and Development Center, Institute of Biomedicine, College of Life Science and Technology, Jinan University, Guangzhou 510632, People’s Republic of China; 3Biomedical Engineering Institute, Jinan University, Guangzhou 510632, People’s Republic of China*These authors contributed equally to this workCorrespondence: Yifei Wang; Zhiping Wang Email twang-yf@163.com; wzping-jshb@gdpu.edu.cnBackground: β-glucans are chiral polysaccharides with well-defined immunological properties and supramolecular wrapping ability of its chiral feature. However, the exploitation of chiral properties of these nanoparticles in drug delivery systems was seldom conducted.Methods: β-glucan molecules with different chain lengths were extracted from yeast Saccharomyces cerevisiae and thereafter modified. In a conformation transition process, these β-glucan molecules were then self-assembled with anti-cancer drug doxorubicin into nanoparticles to construct drug delivery systems. The chiral interactions between the drug and carriers were revealed by circular dichroism spectra, ultraviolet and visible spectrum, fourier transform infrared spectroscopy, dynamic light scattering and transmission electron microscope. The immune-potentiation properties of modified β-glucan nanoparticles were evaluated by analysis of the mRNA expression in RAW264.7 cell model. Further, the antitumor efficacy of the nanoparticles against the human breast cancer were studied in MCF-7 cell model by cellular uptake and cytotoxicity experiments.Results: β-glucan nanoparticles can activate macrophages to produce immune enhancing cytokines (IL-1β, IL-6, TNF-α, IFN-γ). A special chirality of the carriers in diameter of 50∼ 160 nm can also associate with higher drug loading ability of 13.9% ∼ 38.2% and pH-sensitive release with a change of pH from 7.4 to 5.0. Cellular uptake and cytotoxicity experiments also prove that the chiral-active β-glucan nanoparticles can be used in anti-cancer nanomedicine.Conclusion: This work demonstrates that β-glucans nanoparticles with special chiral feature which leading to strong immunopotentiation ability and high drug loading efficiency can be developed as a novel type of nanomedicine for anti-cancer treatment.Keywords: β-glucan, chiral, nanoparticles, doxorubicin, anti-cancer, drug delivery systems, immune-potentiation |
| format |
article |
| author |
Huang J Wu C Tang S Zhou P Deng J Zhang Z Wang Y Wang Z |
| author_facet |
Huang J Wu C Tang S Zhou P Deng J Zhang Z Wang Y Wang Z |
| author_sort |
Huang J |
| title |
Chiral Active β-Glucan Nanoparticles for Synergistic Delivery of Doxorubicin and Immune Potentiation |
| title_short |
Chiral Active β-Glucan Nanoparticles for Synergistic Delivery of Doxorubicin and Immune Potentiation |
| title_full |
Chiral Active β-Glucan Nanoparticles for Synergistic Delivery of Doxorubicin and Immune Potentiation |
| title_fullStr |
Chiral Active β-Glucan Nanoparticles for Synergistic Delivery of Doxorubicin and Immune Potentiation |
| title_full_unstemmed |
Chiral Active β-Glucan Nanoparticles for Synergistic Delivery of Doxorubicin and Immune Potentiation |
| title_sort |
chiral active β-glucan nanoparticles for synergistic delivery of doxorubicin and immune potentiation |
| publisher |
Dove Medical Press |
| publishDate |
2020 |
| url |
https://doaj.org/article/a39b247770c446ceb1bfa5d5e71750b7 |
| work_keys_str_mv |
AT huangj chiralactivebetaglucannanoparticlesforsynergisticdeliveryofdoxorubicinandimmunepotentiation AT wuc chiralactivebetaglucannanoparticlesforsynergisticdeliveryofdoxorubicinandimmunepotentiation AT tangs chiralactivebetaglucannanoparticlesforsynergisticdeliveryofdoxorubicinandimmunepotentiation AT zhoup chiralactivebetaglucannanoparticlesforsynergisticdeliveryofdoxorubicinandimmunepotentiation AT dengj chiralactivebetaglucannanoparticlesforsynergisticdeliveryofdoxorubicinandimmunepotentiation AT zhangz chiralactivebetaglucannanoparticlesforsynergisticdeliveryofdoxorubicinandimmunepotentiation AT wangy chiralactivebetaglucannanoparticlesforsynergisticdeliveryofdoxorubicinandimmunepotentiation AT wangz chiralactivebetaglucannanoparticlesforsynergisticdeliveryofdoxorubicinandimmunepotentiation |
| _version_ |
1718396549703139328 |